Colgate-Palmolive
Colgate-Palmolive
Please review the following presentation in conjunction with our fourth quarter and full year 2024 earnings press release, our fourth quarter and full year
2024 prepared management remarks and additional information regarding our non-GAAP financial measures. Our presentation contains non-GAAP
financial measures, which differ from our reported results prepared in accordance with U.S. generally accepted accounting principles (GAAP). These
non-GAAP financial measures of operating results exclude items that, either by their nature or amount, management would not expe ct to occur as part
of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related
costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. We may also refer to organic sales growth, which is Net
sales growth excluding the impact of foreign exchange, acquisitions and divestments, or to free cash flow before dividends, which we define as Net cash
provided by operations less Capital expenditures. A complete, quantitative reconciliation between our reported results and these non-GAAP financial
measures is available in the Investor Center section of our website at www.colgatepalmolive.com and in Tables 4, 6, 7, 8 and 9 of the fourth quarter and
full year 2024 earnings press release.
Our presentation may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the
Securities and Exchange Commission (the SEC) in its rules, regulations and releases) that set forth anticipated results based on management’s current
plans and assumptions. These statements are made on the basis of our views and assumptions as of February 21, 2025, and we undertake no
obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and
regulations of the SEC. Moreover, we do not, nor does any other person, assume responsibility for the accuracy and completeness of those statements.
We caution investors that forward-looking statements are not guarantees of future performance and actual events or results may differ materially from
those statements. For information about factors that could impact the Company’s business and cause actual results to differ materially from forward-
looking statements, refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors”
and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and
subsequent filings with the SEC). Copies of these filings are available in the Investor Center section of our website at www.colgatepalmolive.com or may
be obtained upon request from the Company’s Investor Relations Department.
WITH ME TODAY
Prabha Narasimhan
EVP, General Manager India
2024 HIGHLIGHTS
● Net sales exceeded $20 billion for the first time
● Organic sales* increased 7.4% (including a 0.5% negative impact from lower private label pet
volume), ahead of initial guidance
● Every category and operating division delivered positive volume growth for the full year as we
work to build household penetration
● Base Business Gross profit margin* increased 240 basis points
● Advertising increased 15% (on top of a 19% increase in 2023) to support building brand health
and strong innovation
● Base Business EPS* increased 11%, ahead of initial guidance
● Delivered record operating cash flow, and returned $3.4 billion in cash to shareholders through
share repurchases and dividends, a 26% increase vs 2023
● Continued to deliver value market share growth in toothpaste, manual toothbrushes and
pet nutrition**
*Non-GAAP **U.S. pet specialty
OUR 2025 OUTLOOK *
● Net sales growth expected to be roughly flat, including a mid-single-digit negative
impact from foreign exchange
● Organic sales growth expected to be within our long-term targeted range of 3% to 5%,
including the impact of the planned exit from private label pet nutrition over the course
of 2025
● Gross profit margin expected to be up for the year
● Advertising expected to be flat to slightly up on a dollar basis and as a percent of net
sales
● GAAP EPS expected to be up mid-single-digits
● Base Business EPS expected to be up low to mid-single-digits
● Drive free cash flow for investing behind growth, dividends, debt paydown and share
repurchases
*As of 4Q 2024 Earnings Release and Conference Call. Does not include any incremental impact from tariffs.
OUR MESSAGE TODAY
● Our strategy is working to deliver consistent compounded
top and bottom line growth
● Increasing household penetration and improving
brand health to drive category growth and market shares
● Delivering productivity and efficiencies to fund advertising
and drive margin expansion
● Driving free cash flow to fund investment and drive
shareholder value
● Living our values every day
OUR MESSAGE TODAY
● Our strategy is working to deliver consistent compounded
top and bottom line growth
● Increasing household penetration and improving
brand health to drive category growth and market shares
● Delivering productivity and efficiencies to fund advertising
and drive margin expansion
● Driving free cash flow to fund investment and drive
shareholder value
● Living our values every day
DELIVERING CONSISTENTLY STRONG
ORGANIC SALES GROWTH
} Target
Range
3-5%
Non-GAAP
GROWTH IN ALL FOUR
CATEGORIES
$20.1
$19.5
$17.4 $18.0
$16.5
$15.5 $15.7
HILL’S
HOME CARE
PERSONAL CARE
ORAL CARE
45%
WE DELIVERED VOLUME GROWTH
ACROSS ALL DIVISIONS IN 2024
Organic volume and pricing
INCREASED ADVERTISING SPENDING
Advertising as % of sales
DRIVING RECORD FREE
CASH FLOW IN 2024
(in billions)
+17%
Non-GAAP
DELIVERED DOUBLE-DIGIT EARNINGS
PER SHARE GROWTH IN 2024
+11.5%
+11.5%
+8.8%
+8.5%
Penetration
FY’24 vs FY’23
35.3%
38.0%
32.3%
’23 ’24 ’23 ’24 ’23 ’24 ’23 ’24 ’23 ’24 31.5%
LATAM
C-P
Comp 1
Comp 2
Comp 3
● Strong digital,
12.9%
influencer
and in store support
Pre-Launch Last Read
Aug ‘24 Dec ‘24
Source: Nielsen
FABULOSO 2X
CONCENTRATED
FORMULA
More Concentrated Fabuloso US Market Share
Formula*
● 2X more active
ingredients*
● Provides 2X
more uses in
the same bottle*
● 50% less plastic**
Source: Nielsen
CONSUMER
CENTRICITY
AI DIGITAL
SCALING
CAPABILITIES
DATA DIGITAL
PERFORMANCE
Data Harmonization For Real-Time Decisions
PERFORMANCE
OPTIMIZATION
● Next frontier in our Revenue Growth Management journey
ELMEX - France
2X
Engagement
Before After
DATA
DIGITAL SHELF SCORES SHOW DIGITAL ANALYTICS
CONTINUOUS IMPROVEMENT
PRODUCT IDEATION:
PROPRIETARY AI FOR ALL
BRANDS AND REGIONS
World-class capabilities built
with latest GenAI technology
Proprietary, bespoke
integrations with CP systems &
processes
2.4x
ROIs CONTINUE TO INCREASE
Prabha Narasimhan
EVP, General Manager India
CP INDIA OPERATES IN A COUNTRY
WITH TREMENDOUS POTENTIAL
0.5X Toothpaste X
Oral Health
Urban #BrushTonight Movement
2023 Onwards
Forging Government Always-on,
Driving behaviour change
all encompassing
Partnerships behaviour change efforts
Dental Check-Ups To include oral health as a
Free Dental Check-ups since narrative into public policy
Bright Smiles, 2004
Bright Futures
Foundational oral health
education in schools
INCREASING HOUSEHOLD PENETRATION
AND IMPROVING BRAND HEALTH
IN CP INDIA
Drive Superiority
Product Creative
Packaging
Superiority Performance
87% 100%
Portfolio had a packaging upgrade
95%
Tracking above norms
Core Brands test superior
vs To aid navigation For ads on air
Competition & win in store
1.7M
Stores covered
30M
SKU x Store combinations
Recommended every month
Source: Internal Data
Source: Kantar HH Panel
INCREASING HOUSEHOLD PENETRATION
AND IMPROVING BRAND HEALTH
IN CP INDIA
Growth Enablers
Superior Technology | Increasing investment | Strong partnership with KOLs
Source: Internal Sales Data, Nielsen Retail Audit
Source: Internal Sales Data, Nielsen Retail Audit
STRONGER & SUPERIOR BRAND
HEALTH
64 69
61 Top of Mind Awareness
10 10 9 12 11 9 8
8 7
2 2 3
2022 2023 2024 2022 2023 2024 2022 2023 2024 2022 2023 2024 2022 2023 2024
62
56 57
Consideration – Brand of First Choice
11 13 14 12 11 11
10 10 11
3 3 3
2022 2023 2024 2022 2023 2024 2022 2023 2024 2022 2023 2024 2022 2023 2024
75 75
74 74
73 73
72
71
2022 2023 2024 2022 2023 2024 2022 2023 2024 2022 2023 2024
+8.3% 33.0%
EBITDA to Net Sales;
2-yr CAGR
+340 bps vs. 2022
1.7x 1.4x
Net Sales growth index EBITDA Margin index vs.
vs. FMCG peers* FMCG peers*
2022 2023 2024 2022 2023 2024 2022 2023 2024 2022 2023 2024 2022 2023 2024
DRY WET
49% 51%
+97%
2.4X 1.7X
H1 H2 H1 H1 H2 H1 H1 H2 H1
2023 2023 2024 2023 2023 2024 2023 2023 2024
+17%
Non-GAAP
CONSISTENT DIVIDEND GROWTH
62 CONSECUTIVE YEARS
OF DIVIDEND INCREASES
$28.5 BILLION
CASH RETURNED TO
SHAREHOLDERS LAST 10 YEARS
Since introducing the first-of-its kind recyclable toothpaste tube in 2019 and as of Dec 31 2024
*Your community may not yet accept tubes for recycling. Check locally. Learn more at colgate.com/goodness.
TRUE CERTIFICATIONS FOR ZERO WASTE
MORE THAN ANY OTHER COMPANY
Gold
Platinum